以岭药业：第三季度净利润3.32亿元 同比增长1264.61%

Core Viewpoint - Yiling Pharmaceutical (002603) reported a significant increase in net profit for Q3 2025, indicating strong financial performance despite a decline in revenue for the first three quarters of the year [1] Financial Performance - Q3 2025 revenue reached 1.827 billion yuan, representing a year-on-year growth of 3.78% [1] - Q3 2025 net profit attributable to shareholders was 332 million yuan, showing a remarkable year-on-year increase of 1264.61% [1] - For the first three quarters of 2025, total revenue was 5.868 billion yuan, reflecting a year-on-year decline of 7.82% [1] - Net profit attributable to shareholders for the first three quarters was 1 billion yuan, which is a year-on-year increase of 80.33% [1]